Diagonal Bio AB (publ) announced the extension of its partnership with Horsholm Veterinary Clinic following the successful completion of a three-month pilot study. Horsholm Veterinary Clinic will continue to use the LAMPlify® system for testing viral infections in horses and harness the potential of the LAMPlify® technology in enhancing horse health and welfare.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0908 SEK | +54.95% | +29.76% | -73.94% |
04-05 | Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic | CI |
04-05 | Diagonal Bio AB Announces Successful Pilot Study Results | CI |
1st Jan change | Capi. | |
---|---|---|
-73.94% | 2.16M | |
+23.37% | 47.02B | |
+49.84% | 41.86B | |
-0.94% | 41.76B | |
-4.27% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
+30.23% | 12.34B | |
-2.67% | 11.82B |
- Stock Market
- Equities
- DIABIO Stock
- News Diagonal Bio AB
- Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic